BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 25796823)

  • 1. [Cytological screening for cervical cancer in the Transcarpathian region].
    Kenïdra AIu; Feĭsa SV
    Wiad Lek; 2014; 67(2 Pt 2):192-5. PubMed ID: 25796823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
    Perkins RB; Anderson BL; Gorin SS; Schulkin JA
    Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current practice patterns in cervical cancer screening in Indiana.
    King NR; Kasper KM; Daggy JK; Tucker Edmonds B
    Am J Obstet Gynecol; 2014 Mar; 210(3):265.e1-8. PubMed ID: 24412744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
    Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
    Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to cervical cancer screening guidelines by gynecologists in the Pacific Northwest.
    Verrilli L; Winer RL; Mao C
    J Low Genit Tract Dis; 2014 Jul; 18(3):228-34. PubMed ID: 24633168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New guidelines for prevention of cervix cancer. ARG report on investigation and treatment of abnormal cytological smears].
    Strander B; Elfgren K; Andrae B
    Lakartidningen; 2011 Mar 9-15; 108(10):533-5. PubMed ID: 21744553
    [No Abstract]   [Full Text] [Related]  

  • 8. Access, access, access: cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
    Milbourne A
    Cancer; 2007 Sep; 110(5):941-2. PubMed ID: 17628490
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing cancer in the symptomatic patient.
    Salzman BE; Lamb K; Olszewski RF; Tully A; Studdiford J
    Prim Care; 2009 Dec; 36(4):651-70; table of contents. PubMed ID: 19913180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
    Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
    Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening intervals, 2006 to 2009: moving beyond annual testing.
    Berkowitz Z; Saraiya M; Sawaya GF
    JAMA Intern Med; 2013 May; 173(10):922-4. PubMed ID: 23568334
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in geographic variation in the uptake of cervical cancer screening in Taiwan: possible effects of "leadership style factor"?
    Chiou ST; Lu TH
    Health Policy; 2014 Jan; 114(1):64-70. PubMed ID: 23981547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening history in women with cervical cancer in a Danish population-based screening program.
    Kirschner B; Poll S; Rygaard C; Wåhlin A; Junge J
    Gynecol Oncol; 2011 Jan; 120(1):68-72. PubMed ID: 21035171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 and type 2 cervical carcinomas: some cervical cancers are more difficult to prevent with screening.
    Austin RM; Zhao C
    Cytopathology; 2012 Feb; 23(1):6-12. PubMed ID: 22243288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of gynecological cytology screening practices among health care providers nationwide.
    Darwish-Yassine M; Garvin AD; Johnston CM; Zoschnick L; Conners A; Laing S; Wojcik C
    Arch Pathol Lab Med; 2015 May; 139(5):650-5. PubMed ID: 25927148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling cost-effectiveness of cervical cancer screening in Hungary.
    Vokó Z; Nagyjánosi L; Margitai B; Kövi R; Tóth Z; László D; Kaló Z
    Value Health; 2012 Jan; 15(1):39-45. PubMed ID: 22264970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening in Latvia: a brief history and recent improvements (2009-2011).
    Vīberga I; Poljak M
    Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(1):27-30. PubMed ID: 23674182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengthening breast and cervical cancer control through partnerships: American Indian and Alaska Native Women and the National Breast and Cervical Cancer Early Detection Program.
    Espey D; Castro G; Flagg T; Landis K; Henderson JA; Benard VB; Royalty JE
    Cancer; 2014 Aug; 120 Suppl 16():2557-65. PubMed ID: 25099898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
    Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
    J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.